Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 4039-4046
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.4039
Figure 1
Figure 1 Systemic IL-9 in healthy individuals and patients with active and inactive inflammatory bowel disease. Data presented as medians with 95%CI and analyzed using Kruskal-Wallis H test. 1Significantly different from other groups.